FDA Inspection
Vitae Enim Vitae Scientific, Inc.Vitae Enim Vitae Scientific, Inc. – FDA Inspection, Jan 7, 2025
Record Details
This FDA Inspection record concerns Vitae Enim Vitae Scientific, Inc., with an inspection on January 7, 2025, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · dd4332f5-ae93-4e20-9070-4506e80f1ce5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1258264
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
7- 21 CFR 211.111Establishment of time limitations
- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.192Extent of discrepancy, failure investigations
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.63Equipment Design, Size and Location
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vitae Enim Vitae Scientific, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 22, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 27, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Vitae Enim Vitae Scientific, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.